leisure time -WSS

leisure time

author：explore 2025-09-30 16:27:40 - browse：28127

Three Wegovy injection pens in a row — first opinion coverage from STAT — Adobe

Novo Nordisk will test whether its GLP-1 drugs can help people with alcohol-associated liver disease, and, as part of that, will study if the treatments will change the amount of alcohol people drink.

This appears to be the first time the company is getting involved in research to see if the booming class of GLP-1 diabetes and obesity drugs can affect substance consumption, a question that academic researchers have been probing but the pharmaceutical industry has so far avoided.

The nine-month study will try three drugs alone and in combinations against placebo. The primary outcome being tested is change in liver scarring, or fibrosis, and one of the secondary outcomes is changes in alcohol consumption. The news of the study was first reported by Bloomberg.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the pharma industry — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Heart attack and stroke risk calculators need revising
Next article： Clinicians often fail to acknowledge the pain caused by long Covid

WSS

Guardant Health colon cancer test endorsed by FDA advisory panel

Beyond aggravation: Constipation is an American epidemic

Teachers share how revamped forgiveness program helped with their student loans

White House announces new plan to address the growing threat of xylazine in overdose crisis

Biden declares emergency in flood

Dozens of beaches across Northeast closed for swimming due to high levels of bacteria in water

focus

leisure time

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the pharma industry — by subscribing to STAT+.

focus

Peter Hotez and the public health issue of online harassment

Duchenne drug from Nippon Shinyaku fails in rare confirmatory trial

George Santos makes 1st court appearance after pleading not guilty to 13 counts

White House announces new plan to address the growing threat of xylazine in overdose crisis

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Medicare wants to send $9 billion to 340B hospitals

State Dept. review finds Biden bears some blame for Afghanistan failures

Unmasking the 'centricity' illusion in clinical trials

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Medical students need to learn the potent medicine of empathy

hotspot

New research sheds light on how often breast cancer is overdiagnosed

Create a giant ice tray with this foil pan hack to keep food cold this summer

Why we need mandatory labeling of GMO products

Louisiana bill approved classifying abortion pills as controlled substances

Giraffe named Twiga, who was among the oldest cared for by humans, died at age 31 at East Texas zoo

Presidential fundraising highlights so far: Trump brings in more than DeSantis

focus

explore

entertainment

entertainment